<DOC>
	<DOCNO>NCT00052429</DOCNO>
	<brief_summary>RATIONALE : Radiation therapy delivers high dose radiation directly tumor may kill tumor cell cause less damage normal tissue . Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining high-dose radiation chemotherapy may kill tumor cell . PURPOSE : Phase I/II trial study effectiveness combine high-dose radiation therapy chemotherapy treat patient newly diagnose stage II , stage III , stage IV nasopharyngeal cancer .</brief_summary>
	<brief_title>High-Dose Radiation Therapy Plus Chemotherapy Treating Patients With Advanced Nose Throat Cancer</brief_title>
	<detailed_description>OUTLINE : Cohorts 10 patient receive follow treatment assess dose-limiting toxicity . Phase I - Radiotherapy : Patients receive radiotherapy daily 5 day week 6 week begin day 1 . - Concurrent chemotherapy : Patients receive cisplatin IV 20-30 minute day 1-5 22-26 . - Adjuvant chemotherapy : Approximately 2-5 week completion radiotherapy , patient receive fluorouracil IV continuously day 1-4 cisplatin IV 20-30 minute day 1-5 22-26 . Treatment repeat every 28 day 3 course absence disease progression unacceptable toxicity . In absence dose-limiting toxicity 1 whole cohort patient , study proceeds phase II . Phase II - Patients treated phase I . Patients follow every 3 month 1 year , every 4 month 1 year , every 6 month 3 year , annually thereafter .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Cisplatin</mesh_term>
	<mesh_term>Fluorouracil</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm nasopharyngeal cancer Stage IIIVB Newly diagnose No distant metastases PATIENT CHARACTERISTICS : Age 18 Performance status Karnofsky 60100 % Life expectancy Not specify Hematopoietic WBC least 3,000/mm^3 Granulocyte count least 1,500/mm^3 Platelet count least 100,000/mm^3 Hemoglobin least 8 g/dL Hepatic Bilirubin great 1.5 time upper limit normal ( ULN ) Alkaline phosphatase great 2.5 time ULN AST great 2.5 time ULN Renal Creatinine great 1.5 mg/dL Creatinine clearance least 60 mL/min Calcium great 11.5 mg/dL Other Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception Medically able tolerate definitive course radiotherapy necessary immobilization No active malignancy within past 3 year except nonmelanoma skin cancer carcinoma situ cervix PRIOR CONCURRENT THERAPY : Biologic therapy Not specify Chemotherapy No prior chemotherapy diagnosis More 3 year since prior chemotherapy Endocrine therapy Not specify Radiotherapy No prior radiotherapy diagnosis More 3 year since prior radiotherapy No prior radiotherapy head neck region Surgery Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>120 Years</maximum_age>
	<verification_date>January 2016</verification_date>
	<keyword>stage II lymphoepithelioma nasopharynx</keyword>
	<keyword>stage II squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage III lymphoepithelioma nasopharynx</keyword>
	<keyword>stage III squamous cell carcinoma nasopharynx</keyword>
	<keyword>stage IV lymphoepithelioma nasopharynx</keyword>
	<keyword>stage IV squamous cell carcinoma nasopharynx</keyword>
</DOC>